Navigation Links
Atomic Tattoos Announces "Tats for Tatas" October Fundraising Event to Benefit Local Breast Cancer Research
Date:10/16/2009

Tampa Bay based Atomic Tattoos has announced the launch of their "Tats for Tatas" fundraising campaign that will take place throughout October, benefitting The Florida Breast Cancer Foundation. In the company's concerted efforts to raise awareness and funds for Breast Cancer Awareness, Atomic is offering several specials throughout the month. In addition, the company will be donating 10% of all proceeds from sales throughout the month of October to directly benefit the Florida Breast Cancer Foundation. The goal of this organization is to establish a state-wide initiative to end breast cancer through advocacy, education and research.

(PRWEB) October 16, 2009 -- Tampa Bay based Atomic Tattoos has announced the launch of their "Tats for Tatas" fundraising campaign that will take place throughout October, benefitting The Florida Breast Cancer Foundation.    In the company's concerted efforts to raise awareness and funds for Breast Cancer Awareness, Atomic is offering several specials throughout the month. In addition, the company will be donating 10% of all proceeds from sales throughout the month of October to directly benefit the Florida Breast Cancer Foundation. The goal of this organization is to establish a state-wide initiative to end breast cancer through advocacy, education and research.

Each of Atomic's Studios in Tampa, Milwaukee, and Orlando will be offering limited edition Pink Ribbon Tattoos for just $50, as well as $15 Pink Body Jewelry. During the entire month of October, all tattoos priced at $100 or more will be discounted by $50, and everyone who participates will receive a $25 gift certificate for a future tattoo or body piercing at Atomic Tattoos.

"Supporting Breast Cancer research is very important to me and everyone at Atomic Tattoos," states Atomic Tattoos CEO and Chairman, Steve Cannon. "We all know so
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

2

GOOD

Page: 1 2

Related medicine news :

1. BODY WORLDS Anatomical Exhibitions of Donor Bodies Receives 28 Millionth Visitor.
2. Ancient fossils shed light on anatomical changes accompanying evolution of first land vertebrates
3. Physics research with atomic force microscope could lead to better health care
4. Minnesota Life Engages Atomic Playpen to Build Market Awareness
5. PLUS Diagnostics Opens West Coast Laboratory to Support Increased Demand for Anatomic Pathology Services
6. Anatomist Dr. Gunther von Hagens, Pioneer of Anatomical Exhibitions Not Affiliated With Copycat Display in Paris
7. Marinela USA(R) Recharges ZumbAtomic for Second Season
8. NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting
9. Online Directory Lists Anatomical Donation Programs in U.S. Offering Free Cremations
10. First atomic-level look at a protein that causes brain disease
11. Fallout From Atomic Bombs Still Causing Health Problems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5New iPhone Application for Anesthesiologists 51079 1New iPhone Application for Anesthesiologists 51079 2BullMarket com Updates Outlook on Healthcare IT Stocks 51074 1BullMarket com Updates Outlook on Healthcare IT Stocks 51074 2Health Caregivers and Allies to Rally 5 p m Weds in Fremont 51070 1Health Caregivers and Allies to Rally 5 p m Weds in Fremont 51070 2